Results 11 to 20 of about 524,934 (294)
Blended Heparin: A new Perspective to Guarantee the Supply of a Life-Saving Drug?
Clinical and Applied Thrombosis/Hemostasis, 2023 The risk of heparin shortage opens up the possibility of diversifying the sources of heparin by introducing products of other animal/organ origins. In addition to bovine heparin, already used in the past in the United States and Europe, ovine heparin can
Marco Guerrini MS
doaj +1 more source
Design of a new type of coating for the controlled release of heparin [PDF]
, 1997 Thrombus formation at the surface of blood contacting devices can be prevented by local release of heparin. Preferably, the release rate should be constant for prolonged periods of time.
Engbers, G.H.M. +4 more
core +3 more sources
Heparin-induced thrombocytopenia: a rare presentation with skin necrosis
Dermatology Reports, 2023 Heparin-induced thrombocytopenia is the most clinically relevant non-haemorrhagic complication of heparin and is characterised by the presence of anti-PF4/heparin-IgG antibodies.
Filipa David +3 more
doaj +1 more source
Gynecology Obstetrics & Reproductive Medicine, 2019 Heparin-induced thrombocytopenia is a rare and life-threatening condition of exposure to heparin. A case of heparin-induced thrombocytopenia due to the low molecular weight heparin was presented.
Yasin Durmuş +8 more
doaj +1 more source
Annals of Vascular Surgery - Brief Reports and Innovations, 2023 Heparin Induced Thrombocytopenia (HIT) is a well-recognized phenomenon in patients receiving heparin. Scoring systems such as the 4T score along with platelet factor 4 (PF4) testing have improved recognition and clinical improvement is typically observed
C.Y. Maximilian Png +5 more
doaj +1 more source
Case Reports in Hematology, 2020 Heparin-induced thrombocytopenia is a life-threatening complication of exposure to heparin. Heparin-induced thrombocytopenia results from an autoantibody directed against platelet factor 4 in complex with heparin.
Mohamed Aon, Omar Al-Shammari
doaj +1 more source
pH-Sensitive Chitosan–Heparin Nanoparticles for Effective Delivery of Genetic Drugs into Epithelial Cells [PDF]
, 2019 Chitosan has been extensively studied as a genetic drug delivery platform. However, its efficiency is limited by the strength of DNA and RNA binding.
Korzhikov-Vlakh, Viktor +7 more
core +1 more source
Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
Frontiers in Molecular Biosciences, 2022 Heparan sulfate (HS) acts as a co-receptor of angiotensin-converting enzyme 2 (ACE2) by interacting with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein (SGP) facilitating host cell entry of SARS-CoV-2 virus ...
Adrianne L. Gelbach +11 more
doaj +1 more source
The ISFET based heparin sensor with a monolayer of protamine as affinity ligand [PDF]
, 1995 The ion-step measuring method was used to determine absolute heparin concentrations in PBS and blood plasma with a Ta2O5 ISFET on to which a monolayer of protamine had been immobilized. Heparin is a highly negatively charged polysaccharide, which is used
Bergveld, P. +2 more
core +2 more sources
Our experience of coronary angiography with and without heparin
Indian Heart Journal, 2012 Aim: Coronary angiography is usually done with heparin. Our aim is to see whether it can be done without heparin through femoral route and its effect on local complications.
Goutam Datta +5 more
doaj +1 more source